Use of growth hormone releasing factor analogs in treating patients suffering from wasting
US7893025B2 · kind B2 · utility
12Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2004 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Jul 26, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for using growth hormone releasing factor analogs of the formula (A), X-GRF Peptide, and pharmaceutically acceptable salts thereof, for increasing muscle function in a subject. Also disclosed herein are corresponding methods, packages and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.